scholarly article | Q13442814 |
P2093 | author name string | B R Cullen | |
D F McCarn | |||
M H Malim | |||
L S Tiley | |||
P2860 | cites work | Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum | Q24300009 |
Visna virus encodes a post-transcriptional regulator of viral structural gene expression | Q24557218 | ||
Subcellular localization of the human immunodeficiency virus trans-acting art gene product | Q24651489 | ||
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins | Q27860587 | ||
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 | ||
DNA sequence and characterization of the S. cerevisiae gene encoding adenylate cyclase | Q27934829 | ||
Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones | Q28237952 | ||
HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region | Q28256243 | ||
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA | Q28279502 | ||
rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA | Q28279513 | ||
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus | Q28299945 | ||
HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency | Q28646762 | ||
HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence | Q28646785 | ||
Use of eukaryotic expression technology in the functional analysis of cloned genes | Q29620166 | ||
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus | Q33562331 | ||
Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif | Q33831166 | ||
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis | Q34049376 | ||
A second post-transcriptional trans-activator gene required for HTLV-III replication | Q34162178 | ||
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. | Q34186306 | ||
Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. | Q34314770 | ||
The human immunodeficiency virus rev protein is a nuclear phosphoprotein | Q34534125 | ||
Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells | Q35837431 | ||
Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products | Q36683132 | ||
Rev-dependent expression of human immunodeficiency virus type 1 gp160 in Drosophila melanogaster cells | Q36773779 | ||
The trypanosome leucine repeat gene in the variant surface glycoprotein expression site encodes a putative metal-binding domain and a region resembling protein-binding domains of yeast, Drosophila, and mammalian proteins | Q36774611 | ||
Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus | Q36793300 | ||
Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs | Q36793376 | ||
Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression | Q36830303 | ||
Leucine periodicity of U2 small nuclear ribonucleoprotein particle (snRNP) A' protein is implicated in snRNP assembly via protein-protein interactions | Q36960061 | ||
Activators and targets | Q37856107 | ||
Pathogenesis of lentivirus infections | Q38164170 | ||
Regulatory pathways governing HIV-1 replication | Q38360638 | ||
Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins | Q40067291 | ||
Phosphorylation of the rev gene product of human immunodeficiency virus type 1. | Q40129721 | ||
High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment. | Q40461112 | ||
Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids | Q41208182 | ||
A human cell factor is essential for HIV-1 Rev action. | Q41235075 | ||
Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro | Q41258164 | ||
Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency | Q41730261 | ||
Nucleotide sequence analysis of SA-OMVV, a visna-related ovine lentivirus: phylogenetic history of lentiviruses | Q41738892 | ||
Regulation by HIV Rev depends upon recognition of splice sites | Q41758926 | ||
Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus | Q42632335 | ||
The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization | Q44022521 | ||
Secondary structure is the major determinant for interaction of HIV rev protein with RNA. | Q45129827 | ||
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 | ||
Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes | Q45831871 | ||
Structural and functional characterization of the human immunodeficiency virus rev protein. | Q45843914 | ||
Sequence-specific RNA binding by the HIV-1 Rev protein. | Q50335727 | ||
Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function | Q58611466 | ||
Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells | Q68504983 | ||
Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype | Q68535819 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virus | Q808 |
P304 | page(s) | 4248-4254 | |
P577 | publication date | 1991-08-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Mutational definition of the human immunodeficiency virus type 1 Rev activation domain | |
P478 | volume | 65 |
Q35227509 | A Comparison of Regulatory Features in Primate Lentiviruses |
Q37635903 | A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation |
Q24322635 | A human nucleoporin-like protein that specifically interacts with HIV Rev |
Q39214476 | A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells |
Q35488480 | A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex. |
Q22009935 | A new nucleoporin-like protein interacts with both HIV-1 Rev nuclear export signal and CRM-1 |
Q34421116 | A novel, mouse mammary tumor virus encoded protein with Rev-like properties |
Q24683176 | A nuclear kinesin-like protein interacts with and stimulates the activity of the leucine-rich nuclear export signal of the human immunodeficiency virus type 1 rev protein |
Q41077534 | A nuclear role for the Fragile X mental retardation protein |
Q64378631 | A peptide inhibitor of exportin1 blocks shuttling of the adenoviral E1B 55 kDa protein but not export of viral late mRNAs |
Q34593969 | A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects |
Q28238195 | A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal beta-actin and viral protein expression |
Q24647511 | A role for nucleoporin FG repeat domains in export of human immunodeficiency virus type 1 Rev protein and RNA from the nucleus |
Q40219824 | ADAR1 is a novel multi targeted anti-HIV-1 cellular protein |
Q41909154 | Adaptive mutations in the nuclear export protein of human-derived H5N1 strains facilitate a polymerase activity-enhancing conformation |
Q24290419 | Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm |
Q24568152 | Amphibian transcription factor IIIA proteins contain a sequence element functionally equivalent to the nuclear export signal of human immunodeficiency virus type 1 Rev |
Q73762090 | Anti-idiotype RNAs that mimic the leucine-rich nuclear export signal and specifically bind to CRM1/exportin 1 |
Q34297734 | Binding of Human Prothymosin α to the Leucine‐Motif/activation Domains of HTLV‐I Rex and HIV‐1 Rev |
Q38358539 | Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition |
Q40041357 | Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus |
Q27860453 | CRM1 is an export receptor for leucine-rich nuclear export signals |
Q39881018 | Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene |
Q28755268 | Characterization of a ribonuclease III-like protein required for cleavage of the pre-rRNA in the 3'ETS in Arabidopsis |
Q45348938 | Characterization of human immunodeficiency virus-1 (HIV-1) rev by (time-resolved) fluorescence spectroscopy |
Q44328482 | Characterization of the caprine arthritis encephalitis virus (CAEV) rev N-terminal elements required for efficient interaction with the RRE. |
Q36562395 | Characterization of the nuclear export signal of human T-cell lymphotropic virus type 1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions |
Q36698908 | Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2. |
Q40045233 | Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. |
Q39870640 | Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes |
Q26851989 | Components and regulation of nuclear transport processes |
Q30603666 | Cooperativity among Rev-associated nuclear export signals regulates HIV-1 gene expression and is a determinant of virus species tropism |
Q28379462 | Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein |
Q40308981 | Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange |
Q24682912 | Determination of the functional domain organization of the importin alpha nuclear import factor |
Q33774771 | Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein |
Q35881335 | Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev. |
Q33987860 | Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production |
Q40044710 | Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. |
Q40066482 | Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance |
Q40113221 | Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif |
Q38296024 | Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding |
Q37145307 | Elevated hypermutation levels in HIV-1 natural viral suppressors |
Q35800195 | Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals |
Q33806883 | Epstein-Barr virus EB2 protein exports unspliced RNA via a Crm-1-independent pathway |
Q36633475 | Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing |
Q24657633 | Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation |
Q28646843 | Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA |
Q28742565 | Evolution of a species-specific determinant within human CRM1 that regulates the post-transcriptional phases of HIV-1 replication |
Q92340071 | Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time |
Q33866139 | Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans- |
Q34529776 | Export of adenoviral late mRNA from the nucleus requires the Nxf1/Tap export receptor |
Q37679611 | Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients |
Q34295820 | Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains |
Q46301219 | Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef. |
Q39579073 | Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface. |
Q28209036 | Functional analysis of the interaction of the human immunodeficiency virus type 1 Rev nuclear export signal with its cofactors |
Q73806944 | Functional role of the HIV-1 Rev exon 1 encoded region in complex formation and trans-dominant inhibition |
Q40475569 | Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences. |
Q33992464 | Gene therapy for infectious diseases |
Q39203103 | Generation of an HIV resistant T-cell line by targeted "stacking" of restriction factors |
Q36333797 | Genetic analysis and gene expression of human immunodeficiency virus |
Q40045693 | Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. |
Q28289718 | HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAs |
Q24671943 | HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing |
Q64121615 | Highly Mutable Linker Regions Regulate HIV-1 Rev Function and Stability |
Q36687462 | Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA |
Q24645943 | Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAs |
Q33350161 | Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression |
Q42800068 | Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells |
Q38953321 | IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms |
Q24678215 | Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K |
Q24321880 | Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins |
Q27933981 | Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast |
Q29547742 | Identification of a signal for rapid export of proteins from the nucleus |
Q33966215 | Identification of novel Saccharomyces cerevisiae proteins with nuclear export activity: cell cycle-regulated transcription factor ace2p shows cell cycle-independent nucleocytoplasmic shuttling |
Q33959518 | Identification of novel import and export signals of human TAP, the protein that binds to the constitutive transport element of the type D retrovirus mRNAs |
Q36655230 | Identification of the activation domain of equine infectious anemia virus rev |
Q40309262 | In vivo binding of wild-type and mutant human immunodeficiency virus type 1 Rev proteins: implications for function |
Q30439541 | Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula |
Q48026294 | Influence of host species on the evolution of the nonstructural (NS) gene of influenza A viruses |
Q24529536 | Influenza B and C virus NEP (NS2) proteins possess nuclear export activities |
Q24523655 | Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1 |
Q37256308 | Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator |
Q35865426 | Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins |
Q36816824 | Inhibition of mRNA export in vertebrate cells by nuclear export signal conjugates |
Q24310012 | Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5 |
Q39579580 | Involvement of human CRM1 (exportin 1) in the export and multimerization of the Rex protein of human T-cell leukemia virus type 1. |
Q24685870 | Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region |
Q34987465 | Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells. |
Q35403061 | Mechanism of action of regulatory proteins encoded by complex retroviruses |
Q41729122 | Mechanisms involved in natural and experimental neuropathogenicity of influenza viruses: evidence and speculation. |
Q37034644 | Molecular mechanisms of HIV-1 vertical transmission and pathogenesis in infants |
Q36687307 | Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS |
Q39581878 | Multimer formation is not essential for nuclear export of human T-cell leukemia virus type 1 Rex trans-activator protein |
Q33603453 | Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells |
Q37596977 | Murine T cells potently restrict human immunodeficiency virus infection |
Q33292384 | Mutational definition of functional domains within the Rev homolog encoded by human endogenous retrovirus K. |
Q27665346 | NES consensus redefined by structures of PKI-type and Rev-type nuclear export signals bound to CRM1 |
Q35924105 | Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells |
Q34353375 | Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein. |
Q24568233 | Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway |
Q40229432 | Nuclear export of simian immunodeficiency virus Vpx protein. |
Q35839437 | Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants |
Q39873549 | Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein. |
Q34381398 | Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. |
Q39740420 | Over-expression of the HIV-1 Rev promotes death of nondividing eukaryotic cells |
Q35846005 | Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual |
Q33648134 | Polyvalent Rev decoys act as artificial Rev-responsive elements |
Q36630676 | Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus. |
Q30879123 | Potent inhibition of HIV-1 replication by a Tat mutant |
Q38180645 | Practical considerations in gene therapy for HIV cure |
Q36561338 | Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay |
Q49485954 | Putative reaction intermediates in Crm1-mediated nuclear protein export |
Q26822052 | Ran-dependent nuclear export mediators: a structural perspective |
Q46400037 | Rapid targeting of nuclear proteins to the cytoplasm |
Q28646696 | Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs |
Q40756505 | Regulation of human immunodeficiency virus infection: implications for pathogenesis |
Q34624049 | Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism |
Q35837448 | Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. |
Q35836276 | Retroviral mRNA nuclear export elements regulate protein function and virion assembly. |
Q37142231 | Rev and Rex proteins of human complex retroviruses function with the MMTV Rem-responsive element |
Q36823499 | Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes |
Q34033155 | Rev protein and its cellular partners |
Q38025392 | Role of Nucleocytoplasmic RNA Transport during the Life Cycle of Retroviruses |
Q24650446 | Role of polyadenylation in nucleocytoplasmic transport of mRNA |
Q36039006 | Role of the RNA recognition motif of the E1B 55 kDa protein in the adenovirus type 5 infectious cycle |
Q33990712 | SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA |
Q40042468 | Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator |
Q30304057 | Selection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 protein |
Q27319151 | Single-Cell and Single-Cycle Analysis of HIV-1 Replication |
Q41981808 | Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication |
Q40910855 | Structural and functional analysis of the avian leukemia virus constitutive transport element |
Q24645046 | Structural and functional analysis of the visna virus Rev-response element |
Q36652433 | Structural and functional characterization of rev-like transcripts of equine infectious anemia virus |
Q36628682 | Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm |
Q21245027 | Substitution of the Rev-response element in an HIV-1-based gene delivery system with that of SIVmac239 allows efficient delivery of Rev M10 into T-lymphocytes |
Q39871345 | Suppression of simian immunodeficiency virus replication by human immunodeficiency virus type 1 trans-dominant negative rev mutants |
Q34976301 | Susceptibility of Mink ( Mustera vision )-Derived Cells to Replication by Human Immunodeficiency Virus Type 1 |
Q39852737 | Synergistic effect of human CycT1 and CRM1 on HIV-1 propagation in rat T cells and macrophages |
Q73342583 | Temperature inducible beta-sheet structure in the transactivation domains of retroviral regulatory proteins of the Rev family |
Q40467685 | The Human Immunodeficiency Virus Type 1 Rev Protein: A Pivotal Protein in the Viral Life Cycle |
Q24538664 | The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells. |
Q40062012 | The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent |
Q39753171 | The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions |
Q38356070 | The hepatitis B virus posttranscriptional regulatory element is composed of two subelements |
Q35898553 | The human T-cell leukemia virus type 1 Rex regulatory protein exhibits an impaired functionality in human lymphoblastoid Jurkat T cells. |
Q35868902 | The human T-cell leukemia virus type 1 posttranscriptional trans-activator Rex contains a nuclear export signal |
Q28646657 | The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences |
Q28254641 | The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export |
Q33888022 | The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins |
Q33605916 | The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes |
Q26801493 | Translational Control of the HIV Unspliced Genomic RNA |
Q37247695 | Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev. |
Q24291654 | Two closely related human nuclear export factors utilize entirely distinct export pathways |
Q36632171 | Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. |
Q39869106 | Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy. |
Q28365327 | Using viral species specificity to define a critical protein/RNA interaction surface |
Q37412098 | Viral factors in non-progression |
Q27938169 | Yeast heat shock mRNAs are exported through a distinct pathway defined by Rip1p |
Q40308472 | trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes |
Search more.